Inventiva Pharma

formerly Inventiva S.A. American Depository SharesIPO

Because patients can't wait

Inventiva Pharma is a biotech company in Daix, France, founded in 2010. It has raised $444.7M across 7 rounds, most recently a $116.0M Growth Equity in May 2025.

Headquarters
Daix
Employees
51–200
Founded
2010
Business Model
B2B
Total Funding
$444.7M
Last Round
$116.0M Growth EquityMay 2025
Rounds
7
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 4 investors for this company. The full record is or through the API.

About

Inventiva is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies for patients with significant unmet medical needs in fibrosis, lysosomal storage disorders, and oncology. Its lead candidate, lanifibranor, is a pan-PPAR agonist in Phase 3 trials for NASH/MASH with breakthrough therapy designation from the FDA. The company has built an extensive proprietary molecule library and wholly-owned R&D capabilities inherited from Abbott, Solvay, and Fournier.

Summary

It lists 51–200 employees. It has raised $444.7M in total across 7 rounds, most recently a $116.0M Growth Equity round in May 2025. Investors include New Enterprise Associates, BVF Partners and Samsara BioCapital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOPublic OfferingNov 2025
$150.0M

Sign up to see all 8 events

Funding: Series A through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inventiva Pharma on Indexed.vc
<a href="https://indexed.vc/companies/inventiva-pharma"><img src="https://indexed.vc/api/badge/company/inventiva-pharma" alt="Inventiva Pharma on Indexed.vc" width="260" height="76" /></a>